Stifel Maintains Buy on Compass Pathways, Raises Price Target to $21

Benzinga Newsdesk www.benzinga.com Positive 79.7%

Neg 0% Neu 0% Pos 79.7%

Stifel analyst Paul Matteis maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the price target from $14 to $21.